myClin

The Leading Clinical Oversight Platform

[myClin @myClin]

Without the ability to track forwarding or attachment opens in emails, it’s nearly impossible to ensure security within a trial. Read our latest blog post at https://t.co/HgjgnP8q7q, to learn how oversight platforms are revolutionizing clinical software in a post-email world.

[myClin @myClin]

Still not convinced email shouldn’t be utilized in clinical trial management? Hear more from Johnny Bilotta, VP of Product Design, on the Hidden Liabilities of Using Email for Clinical Trial Communications at: https://t.co/70LsL8rfCA

[myClin @myClin]

60% of surveyed voters say that chronic inbox overload is the biggest hurdle of using emails in a clinical trial. Thankfully a post email world is here. Read more in our latest blog post, Is it Safe to Use Email in Your Clinical Trial : https://t.co/HgjgnP8q7q

[myClin @myClin]

Happy Halloween! What are the scariest monsters you face using email in your clinical trial?

[myClin @myClin]

How do you stay accountable when managing clinical trials? With email, it’s nearly impossible. There’s no way to see if emails have been read, downloaded, printed, understood, etc. Still not convinced? Watch this insight for Johnny Bilotta’s thoughts: https://t.co/Uxjsww6PZi

[myClin @myClin]

What are some of the biggest hurdles of using emails in a clinical trial?

[myClin @myClin]

Biogen has announced positive data from the clinical trial of its non-opioid pain drug candidate to treat small fiber neuropathy. It works by blocking voltage-dependent and use-dependent voltage-gated sodium channels. Read more about this development: https://t.co/0xPp4IGe6v

[myClin @myClin]

Researchers reported new results for studies testing two types of experimental lymphoma treatments that utilize natural killer cells. Though early results have shown promise, it’s unclear whether they can match the potency of T cell therapies. Read more: https://t.co/YXk5jxGuWK

[myClin @myClin]

Researchers have developed a predictive model of the placebo response in Parkinson's Disease based on patients' psychological traits. This breakthrough is resulting in increased study power of clinical trials & decreased trial timelines & cost. Read more: https://t.co/jA5lUqrpvM

[myClin @myClin]

A new blood test spots cancer in those with genetic predisposition. To develop this test, the researchers applied whole-genome sequencing technology to blood samples from people with and without NF1. Read more: https://t.co/Szd1B8SBvt
#bloodtest #cancer #medtech #research

[myClin @myClin]

A new study describes how adding three chemicals to skin cells causes them to transform into self-renewing muscle cells, potentially offering new treatments for injuries and degenerative diseases. Read more: https://t.co/SLjZdSBLtF
#skinregeneration #skin #research #study

[myClin @myClin]

Researchers reported that blocking certain proteins in cancer cells caused them to die, thus creating potential new targets for drug development. Read more: https://t.co/fxVvM2UP1T
#Research #CancerResearch

[myClin @myClin]

Across the spectrum of eClinical, sponsors and CROs have deployed a myriad of technology - from EDC to IxRS. The electronic Trial Master File is no exception. Learn how to generate contemporaneous evidence of your Good Clinical Practice at: https://t.co/g4fuVmQLCl
#eClinical

[myClin @myClin]

The cause behind why some Parkinson's patients will have their disease turn severe while others may not remains a mystery, but AI researchers at IBM and the Michael J. Fox Foundation believe they may be close to cracking the code. Read more at: https://t.co/XBsLcV8H1l

[myClin @myClin]

New research suggests two druggable pathways, one of which is already being targeted in solid tumors, could be key to beating melanoma. Read more at https://t.co/wsw5hs1ZXc .

[myClin @myClin]

Implementing innovative trial design removed the need for an in house IT department for the Beat AML Master Trial. Read the latest research paper from the Beat AML to learn how at: https://t.co/X0PhtimdgD
#ClinicalResearch #clinicaltrials

[myClin @myClin]

In a first-ever collaborative clinical trial to treat AML, the Beat AML Master Trial set out to streamline the conduct & management of the trial with e-technologies. Read the latest research paper to learn how this was implemented at: https://t.co/y30Yt5BSoZ #BeatAML #MasterTrial

[myClin @myClin]

Researchers at Washington University have discovered immune cells originating in the skull with the sole function of shielding the brain from disease. Read more at https://t.co/1bgTdyzAEf
#brainhealth #medicalresearch #braindisease #immunecells #neuroscience #medicalsciences

[myClin @myClin]

Initial research out of Cleveland Clinic shows new drug targets reduced size of tumors and improved rate-of-survival in mice with treatment-resistant prostate cancer and points to the potential use in humans. Read more at https://t.co/hQ54YJLhJ8.
#cancer #cancertreatment

[myClin @myClin]

Our latest insight post, Their ISF is Your TMF, discusses the importance of your TMF and ISF cohabiting a common electronic space to organize study files in a better, more efficient way. Read more at https://t.co/HRERIWnwtV